Coral Laboratories Limited (BOM:524506)
562.75
-17.10 (-2.95%)
At close: Sep 25, 2026
Coral Laboratories Market Cap
Coral Laboratories has a market cap or net worth of 2.01 billion as of September 25, 2026. Its market cap has increased by 9.27% in one year.
Market Cap
2.01B
Enterprise Value
1.04B
Revenue
967.01M
Ranking
n/a
PE Ratio
10.47
Stock Price
562.75
ChartMarket Cap Chart
Since August 4, 1998, Coral Laboratories's market cap has increased from 39.30M to 2.01B, an increase of 5,015.91%. That is a compound annual growth rate of 15.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 2.01B | 28.34% |
| Dec 31, 2025 | 1.57B | -42.52% |
| Dec 31, 2024 | 2.73B | 75.31% |
| Dec 29, 2023 | 1.55B | 35.01% |
| Dec 30, 2022 | 1.15B | 3.55% |
| Dec 31, 2021 | 1.11B | 0.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sat Kartar Life | 2.83B |
| Medico Remedies | 2.71B |
| Bilcare | 2.62B |
| Gennex Laboratories | 2.47B |
| Everest Organics | 2.33B |
| Accretion Pharmaceuticals | 2.28B |
| Bio Medica Laboratories | 2.12B |
| Sanjivani Paranteral | 2.11B |